• GFC Life Science's largest shareholder Kang Hee Cheol and related parties increased their combined holding to 37.74% from 37.72%.
• Kang bought 1,136 voting shares on November 5–6, 2026, bringing the group's total holdings to 2,009,920 shares and share equivalents.
• The group's voting-share stake rose to 36.98% from 36.95%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GFC Life Science Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261110000139), on November 10, 2026, and is solely responsible for the information contained therein.